FDA approves Paradigm Spine's cost-saving Coflex spinal stenosis treatment

Thu, 10/18/2012 - 8:45am
Mass Device

Paradigm Spine wins FDA approval for the 1st device that treats moderate to severe spinal stenosis with or without back pain, with study results finding that the device preserves motion and saves costs compared with traditional pedicle screw fusion.

Paradigm Spine won FDA approval for its Coflex spinal stenosis treatment system, the 1st such device to treat moderate to severe cases of spinal stenosis that may present with or without back pain.

Paradigm calls the Coflex device the "the 1st and only motion-preserving alternative to fusion for the treatment of moderate to severe spinal stenosis."


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.